Second Generation Taxanes: from the Natural Framework to the Challenge of Drug Resistance
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
133-138
Author(s):
Cristiano Ferlini, Iwao Ojima, Mariagrazia Distefano, Daniela Gallo, Antonella Riva, Paolo Morazzoni, Ezio Bombardelli, Salvatore Mancuso and Giovanni Scambia
Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy
Journal:
Current Drug Targets
Volume:
4
Page:
113-121
Author(s):
Joachim Drevs, Michael Medinger, Carmen Schmidt-Gersbach, Renate Weber and Clemens Unger
Current Targets for Anticancer Drug Discovery
Journal:
Current Drug Targets
Volume:
4
Page:
159-179
Author(s):
Nguyen-Hai Nam and Keykavous Parang
Neuropeptides as Autocrine Growth Factors in Cancer Cells
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
495-509
Author(s):
Terry W. Moody, Daniel Chan, Jan Fahrenkrug and Robert T. Jensen
Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
21-37
Author(s):
C. Ivorra, H. Samyn, M. D. Edo, C. Castro, S. M. Sanz-González, A. Diez-Juan and V. Andres
Advances in Gene Therapy for Bladder Cancer
Journal:
Current Gene Therapy
Volume:
3
Page:
1-11
Author(s):
Akira Irie
Suicide Gene Therapy Mediated by the Herpes Simplex Virus Thymidine Kinase Gene / Ganciclovir System: Fifteen Years of Application
Journal:
Current Gene Therapy
Volume:
3
Page:
13-26
Author(s):
C. Fillat, M. Carrio, A. Cascante and B. Sangro
Application of In Vivo Electroporation to Cancer Gene Therapy
Journal:
Current Gene Therapy
Volume:
3
Page:
59-64
Author(s):
Takahiko Tamura and Tsuneaki Sakata
Novel Approaches to Cancer Therapy Using Oncolytic Viruses
Journal:
Current Molecular Medicine
Volume:
3
Page:
61-71
Author(s):
S. F. Stanziale and Y. Fong
Cancer Chemoprevention Drug Targets
Journal:
Current Drug Targets
Volume:
4
Page:
45-54
Author(s):
K. Krishnan, S. Campbell, F. Abdel-Rahman, S. Whaley and W. L. Stone